CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Jun. 30, 2022		12,493
Beginning balance at Jun. 30, 2022	$ 31,516	$ 1	$ 131,075	$ (98,437)	$ (1,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	602		602
Common stock issued under equity award plans (in shares)		48
Common stock issued under equity award plans	0
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(17)
Shares canceled or surrendered as payment of tax withholding and other	(72)		(72)
Common stock issued under employee stock purchase plan (in shares)		36
Common stock issued under employee stock purchase plan	121		121
Cash dividends	(377)			(377)
Currency translation adjustment	(510)				(510)
Net income (loss)	610			610
Ending balance (in shares) at Sep. 30, 2022		12,560
Ending balance at Sep. 30, 2022	31,890	$ 1	131,726	(98,204)	(1,633)
Beginning balance (in shares) at Jun. 30, 2022		12,493
Beginning balance at Jun. 30, 2022	$ 31,516	$ 1	131,075	(98,437)	(1,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares canceled or surrendered as payment of tax withholding and other (in shares)	(36)
Common stock issued under employee stock purchase plan (in shares)	76
Net income (loss)	$ 574
Ending balance (in shares) at Mar. 31, 2023		12,771
Ending balance at Mar. 31, 2023	33,442	$ 1	133,424	(99,004)	(979)
Beginning balance (in shares) at Jun. 30, 2022		12,493
Beginning balance at Jun. 30, 2022	$ 31,516	$ 1	131,075	(98,437)	(1,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of company stock (in shares)	0
Ending balance (in shares) at Jun. 30, 2023	12,622	12,622
Ending balance at Jun. 30, 2023	$ 34,649	$ 1	134,314	(98,305)	(1,361)
Beginning balance (in shares) at Sep. 30, 2022		12,560
Beginning balance at Sep. 30, 2022	31,890	$ 1	131,726	(98,204)	(1,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	823		823
Common stock issued under equity award plans (in shares)		152
Common stock issued under equity award plans	0
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(5)
Shares canceled or surrendered as payment of tax withholding and other	(19)		(19)
Cash dividends	(381)			(381)
Currency translation adjustment	640				640
Net income (loss)	(1,058)			(1,058)
Ending balance (in shares) at Dec. 31, 2022		12,707
Ending balance at Dec. 31, 2022	31,895	$ 1	132,530	(99,643)	(993)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	817		817
Common stock issued under equity award plans (in shares)		38
Common stock issued under equity award plans	0
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(14)
Shares canceled or surrendered as payment of tax withholding and other	(54)		(54)
Repurchase of company stock (in shares)		0
Repurchase of company stock	$ (383)			(383)
Common stock issued under employee stock purchase plan (in shares)	40	40
Common stock issued under employee stock purchase plan	$ 131		131
Currency translation adjustment	14				14
Net income (loss)	1,022			1,022
Ending balance (in shares) at Mar. 31, 2023		12,771
Ending balance at Mar. 31, 2023	$ 33,442	$ 1	133,424	(99,004)	(979)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of company stock (in shares)	0
Ending balance (in shares) at Jun. 30, 2023	12,622	12,622
Ending balance at Jun. 30, 2023	$ 34,649	$ 1	134,314	(98,305)	(1,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	978		978
Common stock issued under equity award plans (in shares)		281
Common stock issued under equity award plans	0
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(90)
Shares canceled or surrendered as payment of tax withholding and other	(465)		(465)
Repurchase of company stock (in shares)		(145)
Repurchase of company stock	(795)			(795)
Common stock issued under employee stock purchase plan (in shares)		39
Common stock issued under employee stock purchase plan	126		126
Cash dividends	(5,534)			(5,534)
Currency translation adjustment	(294)				(294)
Net income (loss)	629			629
Ending balance (in shares) at Sep. 30, 2023		12,707
Ending balance at Sep. 30, 2023	$ 29,294	$ 1	134,953	(104,005)	(1,655)
Beginning balance (in shares) at Jun. 30, 2023	12,622	12,622
Beginning balance at Jun. 30, 2023	$ 34,649	$ 1	134,314	(98,305)	(1,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares canceled or surrendered as payment of tax withholding and other (in shares)	(200)
Repurchase of company stock (in shares)	(700)
Common stock issued under employee stock purchase plan (in shares)	64
Net income (loss)	$ 1,632
Ending balance (in shares) at Mar. 31, 2024	12,688	12,688
Ending balance at Mar. 31, 2024	$ 26,769	$ 1	136,198	(107,709)	(1,721)
Beginning balance (in shares) at Sep. 30, 2023		12,707
Beginning balance at Sep. 30, 2023	29,294	$ 1	134,953	(104,005)	(1,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	750		750
Common stock issued under equity award plans (in shares)		495
Common stock issued under equity award plans	0
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(34)
Shares canceled or surrendered as payment of tax withholding and other	(213)		(213)
Repurchase of company stock (in shares)		(288)
Repurchase of company stock	(1,876)			(1,876)
Cash dividends	(455)			(455)
Currency translation adjustment	463				463
Net income (loss)	(656)			(656)
Ending balance (in shares) at Dec. 31, 2023		12,880
Ending balance at Dec. 31, 2023	27,307	$ 1	135,490	(106,992)	(1,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	796		796
Common stock issued under equity award plans (in shares)		25
Common stock issued under equity award plans	0
Shares canceled or surrendered as payment of tax withholding and other (in shares)		(38)
Shares canceled or surrendered as payment of tax withholding and other	$ (233)		(233)
Repurchase of company stock (in shares)	(300)	(292)
Repurchase of company stock	$ (1,928)			(1,928)
Common stock issued under employee stock purchase plan (in shares)	25	113
Common stock issued under employee stock purchase plan	$ 145		145
Cash dividends	(448)			(448)
Currency translation adjustment	(529)				(529)
Net income (loss)	$ 1,659			1,659
Ending balance (in shares) at Mar. 31, 2024	12,688	12,688
Ending balance at Mar. 31, 2024	$ 26,769	$ 1	$ 136,198	$ (107,709)	$ (1,721)